Clinical Trials Directory

Trials / Completed

CompletedNCT00265265

Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1

Phase 1, Double-Blind, Placebo-Controlled Multiple Dose Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
16 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess potential interactions between intravenous (i.v.) cocaine and atomoxetine (Strattera) administered orally in four escalating doses.

Conditions

Interventions

TypeNameDescription
DRUGAtomoxetine

Timeline

Start date
2005-08-01
Primary completion
2006-09-01
First posted
2005-12-14
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00265265. Inclusion in this directory is not an endorsement.

Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1 (NCT00265265) · Clinical Trials Directory